Does SIROLIMUS Cause Interstitial lung disease? 129 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 129 reports of Interstitial lung disease have been filed in association with SIROLIMUS (sirolimus). This represents 1.1% of all adverse event reports for SIROLIMUS.
129
Reports of Interstitial lung disease with SIROLIMUS
1.1%
of all SIROLIMUS reports
16
Deaths
95
Hospitalizations
How Dangerous Is Interstitial lung disease From SIROLIMUS?
Of the 129 reports, 16 (12.4%) resulted in death, 95 (73.6%) required hospitalization, and 24 (18.6%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
Yes, Interstitial lung disease is listed as a known adverse reaction in the official FDA drug label for SIROLIMUS.
What Other Side Effects Does SIROLIMUS Cause?
Off label use (1,960)
Drug ineffective (1,005)
Product use in unapproved indication (984)
Transplant rejection (698)
Pneumonia (599)
Product use issue (506)
Alopecia (491)
Acne (482)
Transplant dysfunction (468)
Condition aggravated (433)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which SIROLIMUS Alternatives Have Lower Interstitial lung disease Risk?
SIROLIMUS vs SIRUKUMAB
SIROLIMUS vs SITAGLIPTIN
SIROLIMUS vs SOAP
SIROLIMUS vs SODIUM
SIROLIMUS vs SODIUM BICARBONATE